Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation

<div>(a) CT scan section showing right axillary lymph nodes before treatment. (b) CT scan section showing right axillary lymph nodes 6 weeks after treatment initiation. Arrow shows right axillary lymph nodes being decreased after treatment.</div>

Case Reports in Oncological Medicine

fig4

Figure 4

Figure 4: Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation 